source
- Kyverna Therapeutics aims to file first CAR-T cell therapy for autoimmune diseaseKyverna Therapeutics is preparing what could become the first regulatory filing for a CAR-T cell therapy targeting an autoimmune condition. The company has been developing its miv-cel construct in…
- HHS vaccine committee receives new charter amid broader health policy updatesThe U.S. Health and Human Services vaccine advisory panel has been granted a new charter, a change that was noted quietly in a recent health newsletter. The same briefing highlighted other policy…